Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

193 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neoadjuvant Cytoreductive Treatment With BRAF/MEK Inhibition of Prior Unresectable Regionally Advanced Melanoma to Allow Complete Surgical Resection, REDUCTOR: A Prospective, Single-arm, Open-label Phase II Trial.
Blankenstein SA, Rohaan MW, Klop WMC, van der Hiel B, van de Wiel BA, Lahaye MJ, Adriaansz S, Sikorska K, van Tinteren H, Sari A, Grijpink-Ongering LG, van Houdt WJ, Wouters MWJM, Blank CU, Wilgenhof S, van Thienen JV, van Akkooi ACJ, Haanen JBAG. Blankenstein SA, et al. Among authors: van de wiel ba, van akkooi acj, van houdt wj, van thienen jv, van der hiel b, van tinteren h. Ann Surg. 2021 Aug 1;274(2):383-389. doi: 10.1097/SLA.0000000000004893. Ann Surg. 2021. PMID: 33843797 Clinical Trial.
Prognosis of Primary and Recurrent Chondrosarcoma of the Rib.
Roos E, van Coevorden F, Verhoef C, Wouters MW, Kroon HM, Hogendoorn PC, van Houdt WJ. Roos E, et al. Among authors: van houdt wj, van coevorden f. Ann Surg Oncol. 2016 Mar;23(3):811-7. doi: 10.1245/s10434-015-4932-2. Epub 2015 Oct 23. Ann Surg Oncol. 2016. PMID: 26498768
Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma.
Tetzlaff MT, Messina JL, Stein JE, Xu X, Amaria RN, Blank CU, van de Wiel BA, Ferguson PM, Rawson RV, Ross MI, Spillane AJ, Gershenwald JE, Saw RPM, van Akkooi ACJ, van Houdt WJ, Mitchell TC, Menzies AM, Long GV, Wargo JA, Davies MA, Prieto VG, Taube JM, Scolyer RA. Tetzlaff MT, et al. Among authors: van de wiel ba, van akkooi acj, van houdt wj. Ann Oncol. 2018 Aug 1;29(8):1861-1868. doi: 10.1093/annonc/mdy226. Ann Oncol. 2018. PMID: 29945191 Free PMC article.
Outcome after surgical treatment of dermatofibrosarcoma protuberans: Is clinical follow-up always indicated?
Huis In 't Veld EA, van Coevorden F, Grünhagen DJ, Smith MJ, van Akkooi ACJ, Wouters MWJM, Hayes AJ, Verhoef C, Strauss DC, van Houdt WJ. Huis In 't Veld EA, et al. Among authors: van akkooi acj, van houdt wj, van coevorden f. Cancer. 2019 Mar 1;125(5):735-741. doi: 10.1002/cncr.31924. Epub 2019 Jan 15. Cancer. 2019. PMID: 30644528 Free article.
High response rates for T-VEC in early metastatic melanoma (stage IIIB/C-IVM1a).
Franke V, Berger DMS, Klop WMC, van der Hiel B, van de Wiel BA, Ter Meulen S, Wouters MWJM, van Houdt WJ, van Akkooi ACJ. Franke V, et al. Among authors: van de wiel ba, van akkooi acj, van houdt wj, van der hiel b. Int J Cancer. 2019 Aug 15;145(4):974-978. doi: 10.1002/ijc.32172. Epub 2019 Feb 21. Int J Cancer. 2019. PMID: 30694555 Free article.
Surgical removal of the index node marked using magnetic seed localization to assess response to neoadjuvant immunotherapy in patients with stage III melanoma.
Schermers B, Franke V, Rozeman EA, van de Wiel BA, Bruining A, Wouters MW, van Houdt WJ, Ten Haken B, Muller SH, Bierman C, Ruers TJM, Blank CU, van Akkooi ACJ. Schermers B, et al. Among authors: van de wiel ba, van akkooi acj, van houdt wj. Br J Surg. 2019 Apr;106(5):519-522. doi: 10.1002/bjs.11168. Epub 2019 Mar 18. Br J Surg. 2019. PMID: 30882901 Free PMC article. Clinical Trial.
193 results